Oxyntomodulin: Actions and role in diabetes

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Research

Background:

• Oxyntomodulin is a 37-amino acid peptide hormone derived from the proglucagon precursor.
• It is produced and released by endocrine L-cells in the gastrointestinal tract.
• Enzymatic processing by prohormone convertase 1/3 generates oxyntomodulin from proglucagon.

Purpose of the Study:

• To provide an updated overview of oxyntomodulin.
• To focus on the potential therapeutic applications of oxyntomodulin in metabolic diseases.
• To highlight its unique dual receptor activity.

Main Methods:

• Review of existing literature on oxyntomodulin.
• Analysis of proglucagon processing pathways.
• Examination of oxyntomodulin's receptor binding and signaling.

Main Results:

• Oxyntomodulin exhibits glucagon-like bioactivity.
• Oxyntomodulin unexpectedly activates the glucagon-like peptide-1 (GLP-1) receptor.
• This dual activity positions oxyntomodulin as a glucagon-GLP-1 co-agonist.

Conclusions:

• Oxyntomodulin's dual agonism is of significant interest for metabolic disease treatment.
• Its potential in managing diabetes and obesity warrants further investigation.
• Oxyntomodulin represents a promising therapeutic target for metabolic disorders.